Bambusa Therapeutics Prices Upsized IPO at Midpoint, Raising About $169 Million
The clinical-stage biopharmaceutical company said it is selling shares. Its shares are set to begin trading Friday.
The clinical-stage biopharmaceutical company said it is selling shares. Its shares are set to begin trading Friday.